Excellent long-term outcomes of ABO-incompatible kidney transplantation in children

Seiichirou Shishido, Hiroshi Asanuma, Hiroyuki Satoh, Manabu Saneshige, Yoshihito Nanpo

Research output: Contribution to journalArticle

Abstract

Due to profound shortage of suitable deceased allografts, much effort has been made to investigate whether successful kidney transplantation is possible across the ABO blood group barrier even for pediatric recipients. Methods: Twenty-five pediatric patients underwent ABO-incompatible living kidney transplantation. All patients received three sessions of plasmapheresis (PP) or immunoadsorption (IA) to remove the anti-A/B antibodies before transplantation. This was followed by splenectomy and a conventional quadruple drug immunosuppressive protocol. To prevent overwhelming postsplenectomy infections, penicillin prophylaxis as well as pretransplant pneumococcal vaccine was given to all patients. Results: Of 25 patients, 12 grafts had rebound increases in their anti-A/B isoagglutinin titers within 10 days posttransplant. Moreover, 10 of 12 (83%) patients developed acute rejection with the increase of isoagglutinins. One patient lost the graft because of uncontrolled delayed hyperacute rejection, while the other nine acute rejection episodes were reversed with a standard anti-rejection therapy in combination with PP/IA. Four patients had severe bacterial infectious complications after transplantation. The actuarial 1-, 5- and 10-year graft survival rates are 96%, 91% and 91%, respectively. Conclusions: With the adequate desensitization protocol, ABO-incompatible kidney transplantation is a valid alternative even for children with end stage renal disease.

Original languageEnglish
Pages (from-to)42-49
Number of pages8
JournalInternational Congress Series
Volume1292
DOIs
Publication statusPublished - 2006 Jul
Externally publishedYes

Fingerprint

Kidney Transplantation
Plasmapheresis
Transplantation
Pediatrics
Pneumococcal Vaccines
Graft Survival
Splenectomy
Immunosuppressive Agents
Blood Group Antigens
Penicillins
Immunosuppression
Chronic Kidney Failure
Allografts
Survival Rate
Transplants
Antibodies
Infection
Pharmaceutical Preparations

Keywords

  • ABO-incompatibility
  • Children
  • Kidney transplantation
  • Plasmapheresis
  • Splenectomy

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Excellent long-term outcomes of ABO-incompatible kidney transplantation in children. / Shishido, Seiichirou; Asanuma, Hiroshi; Satoh, Hiroyuki; Saneshige, Manabu; Nanpo, Yoshihito.

In: International Congress Series, Vol. 1292, 07.2006, p. 42-49.

Research output: Contribution to journalArticle

Shishido, Seiichirou ; Asanuma, Hiroshi ; Satoh, Hiroyuki ; Saneshige, Manabu ; Nanpo, Yoshihito. / Excellent long-term outcomes of ABO-incompatible kidney transplantation in children. In: International Congress Series. 2006 ; Vol. 1292. pp. 42-49.
@article{e82ff22a2bce4369b1b0c75d4b1a01b1,
title = "Excellent long-term outcomes of ABO-incompatible kidney transplantation in children",
abstract = "Due to profound shortage of suitable deceased allografts, much effort has been made to investigate whether successful kidney transplantation is possible across the ABO blood group barrier even for pediatric recipients. Methods: Twenty-five pediatric patients underwent ABO-incompatible living kidney transplantation. All patients received three sessions of plasmapheresis (PP) or immunoadsorption (IA) to remove the anti-A/B antibodies before transplantation. This was followed by splenectomy and a conventional quadruple drug immunosuppressive protocol. To prevent overwhelming postsplenectomy infections, penicillin prophylaxis as well as pretransplant pneumococcal vaccine was given to all patients. Results: Of 25 patients, 12 grafts had rebound increases in their anti-A/B isoagglutinin titers within 10 days posttransplant. Moreover, 10 of 12 (83{\%}) patients developed acute rejection with the increase of isoagglutinins. One patient lost the graft because of uncontrolled delayed hyperacute rejection, while the other nine acute rejection episodes were reversed with a standard anti-rejection therapy in combination with PP/IA. Four patients had severe bacterial infectious complications after transplantation. The actuarial 1-, 5- and 10-year graft survival rates are 96{\%}, 91{\%} and 91{\%}, respectively. Conclusions: With the adequate desensitization protocol, ABO-incompatible kidney transplantation is a valid alternative even for children with end stage renal disease.",
keywords = "ABO-incompatibility, Children, Kidney transplantation, Plasmapheresis, Splenectomy",
author = "Seiichirou Shishido and Hiroshi Asanuma and Hiroyuki Satoh and Manabu Saneshige and Yoshihito Nanpo",
year = "2006",
month = "7",
doi = "10.1016/j.ics.2006.03.055",
language = "English",
volume = "1292",
pages = "42--49",
journal = "International Congress Series",
issn = "0531-5131",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Excellent long-term outcomes of ABO-incompatible kidney transplantation in children

AU - Shishido, Seiichirou

AU - Asanuma, Hiroshi

AU - Satoh, Hiroyuki

AU - Saneshige, Manabu

AU - Nanpo, Yoshihito

PY - 2006/7

Y1 - 2006/7

N2 - Due to profound shortage of suitable deceased allografts, much effort has been made to investigate whether successful kidney transplantation is possible across the ABO blood group barrier even for pediatric recipients. Methods: Twenty-five pediatric patients underwent ABO-incompatible living kidney transplantation. All patients received three sessions of plasmapheresis (PP) or immunoadsorption (IA) to remove the anti-A/B antibodies before transplantation. This was followed by splenectomy and a conventional quadruple drug immunosuppressive protocol. To prevent overwhelming postsplenectomy infections, penicillin prophylaxis as well as pretransplant pneumococcal vaccine was given to all patients. Results: Of 25 patients, 12 grafts had rebound increases in their anti-A/B isoagglutinin titers within 10 days posttransplant. Moreover, 10 of 12 (83%) patients developed acute rejection with the increase of isoagglutinins. One patient lost the graft because of uncontrolled delayed hyperacute rejection, while the other nine acute rejection episodes were reversed with a standard anti-rejection therapy in combination with PP/IA. Four patients had severe bacterial infectious complications after transplantation. The actuarial 1-, 5- and 10-year graft survival rates are 96%, 91% and 91%, respectively. Conclusions: With the adequate desensitization protocol, ABO-incompatible kidney transplantation is a valid alternative even for children with end stage renal disease.

AB - Due to profound shortage of suitable deceased allografts, much effort has been made to investigate whether successful kidney transplantation is possible across the ABO blood group barrier even for pediatric recipients. Methods: Twenty-five pediatric patients underwent ABO-incompatible living kidney transplantation. All patients received three sessions of plasmapheresis (PP) or immunoadsorption (IA) to remove the anti-A/B antibodies before transplantation. This was followed by splenectomy and a conventional quadruple drug immunosuppressive protocol. To prevent overwhelming postsplenectomy infections, penicillin prophylaxis as well as pretransplant pneumococcal vaccine was given to all patients. Results: Of 25 patients, 12 grafts had rebound increases in their anti-A/B isoagglutinin titers within 10 days posttransplant. Moreover, 10 of 12 (83%) patients developed acute rejection with the increase of isoagglutinins. One patient lost the graft because of uncontrolled delayed hyperacute rejection, while the other nine acute rejection episodes were reversed with a standard anti-rejection therapy in combination with PP/IA. Four patients had severe bacterial infectious complications after transplantation. The actuarial 1-, 5- and 10-year graft survival rates are 96%, 91% and 91%, respectively. Conclusions: With the adequate desensitization protocol, ABO-incompatible kidney transplantation is a valid alternative even for children with end stage renal disease.

KW - ABO-incompatibility

KW - Children

KW - Kidney transplantation

KW - Plasmapheresis

KW - Splenectomy

UR - http://www.scopus.com/inward/record.url?scp=33748950096&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748950096&partnerID=8YFLogxK

U2 - 10.1016/j.ics.2006.03.055

DO - 10.1016/j.ics.2006.03.055

M3 - Article

VL - 1292

SP - 42

EP - 49

JO - International Congress Series

JF - International Congress Series

SN - 0531-5131

ER -